Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients
Clinical trial NCT05321329 · UNKNOWN
Trial details
- NCT number
- NCT05321329
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2023-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.